A father diagnosed with Motor Neurone Disease (MND) is supporting a fundraising campaign to accelerate a clinical trial for a drug that could potentially reverse the disease. The drug, Ellorarxine, has received approval to begin trials.
A dad with motor neurone disease has backed a £350,000 campaign to help researchers fund a clinical trial for a drug aimed at reversing the condition. Mark Sommerville has teamed up with Tony Lockett and Andy Whiting, from Nevrargenics, who are behind a drug which they believe not only stops the impact of MND but reverses the damage already done.
Their lead drug, Ellorarxine, has just been approved by the UK MHRA to begin its first clinical trial in MND and Frontotemporal dementia (FTD) patients. However to accelerate the clinical trial process and begin critical manufacturing, they need to raise £350,000 to advance the early-phase work required to bring Ellorarxine to patients. Mark, 43, who was given his devastating diagnosis in October and told he had 18 months to live, has backed Nevrargenics’ campaign. Dad-of-four Mark, from Uddingston in Lanarkshire, said: “MND is a battle against a cruel, life-limiting illness, with no effective treatment options available. “This new drug is something that no one has ever done before. There is no cure for MND, so everything must be done and everything must be done to give people a chance. What have we got to lose? Only everything to gain.” Whiting, the chief executive officer of Nevargenics said the company’s “plan is to get Ellorarxine into MND patients before the end of 2025”. Mark set up the Mark Sommerville Foundation to fund research and believes more needs to be done by governments to help find a cure. Top news stories today Last month we told how Mark was singled out for support by Prime Minister Keir Starmer. His case was highlighted by Labour MP for Coatbridge and Bellshill Frank McNally, who called for the government to increase funding into research for a cure. Starmer recognised Mark’s work and that of rugby league star Kevin Sinfield, who has raised another million for MND sufferers – the disease that took best pal Rob Burrow in June at the age of just 4
Science MOTOR NEURONE DISEASE DRUG TRIAL ELLORARXINE RESEARCH FUNDRAISING
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
PM Backs Dad with Motor Neurone Disease in Push for More ResearchMark Sommerville, a dad battling motor neurone disease, received support from Prime Minister Keir Starmer during a campaign for increased research funding. Sommerville and his foundation aim to raise awareness and funding to find a cure for the debilitating condition.
Read more »
Scots Dad Dies Two Years After Motor Neurone Disease DiagnosisScott Stewart, 42, passed away after being initially dismissed by his GP when he first raised concerns about his health. Stewart was diagnosed with MND in August 2022 and leaves behind his wife and young daughter.
Read more »
Potential new treatment for motor neurone disease shows promising resultsA potential new treatment for motor neurone disease (MND) developed by a company spun-out of The University of Queensland has produced successful results in a human clinical trial.
Read more »
Welsh rugby legend Geoff Wheel dies aged 73 after battle with Motor Neurone disease...Headline Motor neurone disease hits you like a brick – it’s the loss of the future you thought you had, Instagram
Read more »
Rugby legend dies aged 73 after secret battle with motor neurone diseaseRugby Legend Geoff Wheel has sadly passed away aged 73 after battling with Motor Neurone Disease, with the tragic news being confirmed on Boxing Day by his former club, Swansea.
Read more »
Aspiring Surgeon, 38, Faces Two-Year Life Expectancy After Devastating MND DiagnosisJeffrey Jenkins, a 38-year-old aspiring pediatric surgeon, has been diagnosed with Motor Neurone Disease (MND) and given a life expectancy of two years. Jenkins had been managing Graves' disease, an autoimmune condition affecting the thyroid, for decades, but his symptoms worsened in 2024, leading to the MND diagnosis. His family believes the disease may have been misdiagnosed earlier due to the stress of his medical studies. Jenkins' condition has progressed rapidly, causing weakness in his hands and arms, making it difficult to perform everyday tasks.
Read more »